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Synopsis 
AP-2a, a 52 kDa sequence-spec~fic DNA-binding transcnptlon factor was identified as a 
large T antigen interacting proteln AP-2 is a family of proteins currently having five 
members namely AP-2a, AP-2f3, AP-2y, AP-26 and AP-2~ AP-2a is shown to induce 
the transcnptlon of a vanety of genes that regulate diverse cellular processes like cell 
cycle progression, angiogenesis, transforrna~on, development and chfferentiation. AP- 
2a IS an essential gene since the AP-2a knockout is embryonically lethal There is a 
mounhng body of evidence, which suggest that AP-2a is a tumor suppressor Firstly, 
AP-2a is located on chromosome 6 at the HLA locus the most common LOH in breast 
and vanous other cancers Secondly, AP-2a interacts with viral oncoproteins Large T 
antigen and adenovirus ElA, which inhibits its activity Thlrdly, oncogenes like Ras 
although increase the AP-2a mRNA levels but ~nhibits its function This study is carned 
out to functionally characterize AP-2a as a tumor suppressor and to evaluate its potenhal 
as anh-cancer agent 
The thesis has follow~ng sections- 
1 Construchon and characterization of a recombinant adenovirus express~ng AP-2a 
2 Regulation of cell cycle by AP-2a 
3 Mechanism of apoptosis induction by AP-2a 
4 Role of AP-2a in cancer cell chemosensitiv~ty 
AP-2a expression 1s found to be lost in advanced stages of vanous cancers To 
unequivocally prove the role of AP-2a as a tumor suppressor, we have generated and 
H 
charactenzed a replication-deficient recombinant adenovirus expressing AP-2a (Ad- 
AP2) Ad-AP2 expressed funct~onal AP-2a as the cells infected with Ad-AP2 showed 
induced levels of AP-2a protein, which bound to DNA in a sequence-speclfic manner 
and activated the AP-2-spec~fic reporter 3X-AP2 CAT Infection wlth Ad-AP2 resulted 
in potent cytotoxicity in several cell lines tested The mechanism of AP-2a induced 
cytotoxic~ty was found to be a combination of ~nhibit~on of cellular DNA synthes~s 
lead~ng to cell cycle arrest and induction of apoptosis We found that the AP-2a 
mediated apoptosis is mostly independent of p53, although p53 is found to enhance the 
apoptosis caused by AP-2a Further, we found AP-2a overexpresion enhanced the 
chemosensihvity of cancer cells to commonly used anti-cancer drugs ahamycin and 
cisplatm Moreover, our results show that Ad-AP2 mfecbon in normal cells does not 
induce apoptosis and is only very marg~nally growth inhib~tory to normal cells as ~t 
induces cell cycle arrest These results suggest that Ad-AP2 could be used as a potent 
anti-cancer agent 
Among the mechanisms that cells have developed to cope with constant attack on 
DNA is halting cell cycle progression or undergoing programmed cell death (Apoptosis) 
We found that overexpresslon of AP-2a, arrest the cells in Gl/S phase of the cell cycle 
We found that, p21WAF1""1, a previo~sly ldent~fied transcnpt~onal target of AP-2a, is 
Induced in Ad-AP2 infected cells and is required for AP-2a mediated cell cycle arrest 
Analys~s of levels of vanous cdks and cyclins revealed that cyclln D2 1s repressed in a 
time-dependent manner in Ad-AP2 Infected cells Accordingly, the activlty of 
cycllnDlCDK4 and cyclinDICDK6, but not cyclmE/CDK2 and cyclinBICDK1, was 
found inhibited in AP-2a overexpresslng cells Real-time RT-PCR analysis revealed 
that cycltnD transcripts are indeed repressed significantly Ad-AP2 tnfected cells These 
results suggest that AP-Zainduces cell cycle arrest through inhibition of 
cyclinD/CDK416 complexes by transcriptional down regulation of cyclinD2 
Apoptosis induction is one of the mechanisms by which tumor suppressor 
proteins regulate the cell proliferatton from preventing the nomal cell to become 
neoplastic We investigated the mechanism of apoptosis inducbon by AP-2a We found 
that the effector caspase 3 IS important for AP-2a adenovirus (Ad-AP2) to induce 
apoptosls Although both initiator caspases, caspase 8 and 9 were found to be activated 
In AP-2a overexpressing cells, we establish that AP-2a pnrnanly utilizes the 
rmtochondnal pathway to Induce apoptosis by using caspases specific inhibitors In 
good correlation, cells overexpressing AP-2a showed a reduchon in rmtochondnal 
membrane potenlral (Ay,), cytochrome c and Smac/DIABLO release into cytosol, and 
Bax translocation into mitochondria AP-2a faded to induce apoptosls in the absence of 
Bax, which correlated with the inability of Ad-AP2 to inhibit the growth of HCT116 
I3axJ' cells m VZ~I-o and zn vrvo in nude rmce model In addibon, we found Apafl 
essential wh~le the IAP (Inhibitor of apoptosls) inhibitor SmacIDIABLO may have a 
lirmted role as AP-2a down regulated Survivm, a member of IAP farmly Although the 
total Bax levels remain unaltered, we found a time-dependent increase in acbvated form 
of Bax in Ad-AP2-infected cells Further, we show that AP-2a transcriptionally down 
regulates Bcl-2 and is essential for AP-2a-induced apoptosis as ectopic expression of 
Bcl-2 inhibited cytotoxicity and apoptosis induced by AP-2a efftc~ently These results 
suggest that AP-2a tnduces apoptosis by down regulating Bcl-2 and utdizlng 
bax/cytochrome clApaf llcaspase 9-dependent rnl tochondnal pathway 
1v 
Cancer chemotherapeutic drugs induce apoptosis by several pathways 
Inactivation of proapoptotic genes or activation of survival signaling leads to 
chemoresistance We show that controlled expression of AP-2a, using tetracycline 
inducible system, increased the chemosensitivity of cancer cells by sensit~zing them to 
undergo apoptosis upon chemotherapy Under these conditions, neither AP-2a 
expression nor chemotherapy resulted in apoptosis inducQon while in combination, the 
cancer cells underwent massive apoptosis We found chemotherapy induced endogenous 
AP-2a, which contributed to chemosensitivity as simultaneous silencing by AP-2a 
siRNA resulted in chernoresistance in a p53 independent manner In adhtlon, we show 
that 5-aza-2'deoxycytidine (5aza2dC) induced re-expression of AP-2a in MDA-MB-23 1 
breast cancer cells, wherein AP-2a expression is epigenetically sllenced by promoter 
hypermethylat~on, resulted m ~ncreased chemosensitivity and loss of tumongenesis upon 
chemotherapy in an AP-2a dependent manner These results establish an important role 
for AP-2a in cancer cell chemosensitwity Although p53 is one of the major 
detemnants of cancer cell chemosensitivity, the fact that p53 is mutated in more than 
50% of human cancers, identdication of additional chemosensitivity detemnants is very 
important for effective chemotherapy As our results show that AP-2a status deterrmnes 
the chemosensitivity in the absence of p53, we propose AP-2a IS an important 
chemosensi~vity deterrmnant We also provide evidence that AP-2a contnbutes to 
chemotherapy induced apoptosis as well as both zn vztro and m vzvo validation for a 
strategy to reverse chemoresistance in human cancers, In pmcular breast cancer and 
underscores the value of tailonng cancer therapy on the basis of tumor genotype 
